Analyst's Research
An Alluring Acquisition Proposal Is Raising Pasithea (KTTA) Stock Up 26% Today
Pasithea Therapeutics Corp. (NASDAQ: KTTA) surged by a remarkable 26% to $0.5040 during early trading on Monday. In the previous session, KTTA witnessed a substantial